Role of androgen receptor in prostate cancer cell cycle regulation: Interaction with cell cycle regulatory proteins and enzymes of DNA synthesis

Current Protein and Peptide Science

Volumn 11, Issue 6, 2010, Pages 451-458

  Sivanandam, Arun ^a   Murthy, Shalini ^a   Kim, Sahn Ho ^a   Barrack, Evelyn R ^a   Reddy, G Prem Veer ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

And Prostate Cancer; Androgen Receptor; Cell Cycle; DNA Replication; Pre Replication Complex

Indexed keywords

ANDROGEN RECEPTOR; DNA;

ARTICLE; CANCER CELL; CELL CYCLE REGULATION; CELL PROLIFERATION; DNA REPLICATION; DNA SYNTHESIS; PROSTATE CANCER; PROTEIN INTERACTION;

CELL CYCLE; CELL CYCLE PROTEINS; DNA; DNA REPLICATION; HUMANS; MALE; MULTIENZYME COMPLEXES; PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, ANDROGEN;

EID: 78651343020     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920310791824075     Document Type: Article

References (75)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancerstatistics, 2009. CA. Cancer J. Clin., 2009, 59, 225-49.
2. Yuan, X.; Balk, S. P. Mechanisms mediating androgen receptorreactivation after castration. Urol. Oncol., 2009, 27, 36-41.
3. Dutt, S. S.; Gao, A. C. Molecular mechanisms of castrationresistantprostate cancer progression. Future Oncol., 2009, 5, 1403-13.
4. Chen, Y.; Sawyers, C. L.; Scher, H. I. Targeting the androgenreceptor pathway in prostate cancer. Curr. Opin. Pharmacol., 2008,8, 440-8.
5. Feldman, B. J.; Feldman, D. The development of androgenindependentprostate cancer. Nat. Rev. Cancer, 2001, 1, 34-45.
6. Snoek, R.; Cheng, H.; Margiotti, K.; Wafa, L. A.; Wong, C. A.; Wong, E. C.; Fazli, L.; Nelson, C. C.; Gleave, M. E.; Rennie, P. S. Invivo knockdown of the androgen receptor results in growth inhibitionand regression of well-established, castration-resistant prostatetumors. Clin. Cancer Res., 2009, 15, 39-47.
7. Eder, I. E.; Culig, Z.; Ramoner, R.; Thurnher, M.; Putz, T.; Nessler-Menardi, C.; Tiefenthaler, M.; Bartsch, G.; Klocker, H. Inhibitionof Lnca P prostate cancer cells by means of androgen receptor antisenseoligonucleotides. Cancer Gene Ther., 2000, 7, 997-1007.
8. Zegarra-Moro, O. L.; Schmidt, L. J.; Huang, H.; Tindall, D. J. Disruptionof androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res., 2002, 62, 1008-1013.
9. Haag, P.; Bektic, J.; Bartsch, G.; Klocker, H.; Eder, I. E. Androgenreceptor down regulation by small interference RNA induces cellgrowth inhibition in androgen sensitive as well as in androgen independentprostate cancer cells. J. Steroid Biochem. Mol. Biol., 2005, 96, 251-258.
10. Liao, X.; Tang, S.; Thrasher, J. B.; Griebling, T. L.; Li, B. Smallinterfering RNA-induced androgen receptor silencing leads toapoptotic cell death in prostate cancer. Mol. Cancer Ther., 2005, 4,505-515.
11. Dehm, S. M.; Tindall, D. J. Molecular regulation of androgen actionin prostate cancer. J. Cell Biochem., 2006, 99, 333-344.
12. Pandini, G.; Mineo, R.; Frasca, F.; Roberts, C. T., Jr.; Marcelli, M.; Vigneri, R.; Belfiore, A. Androgens up-regulate the insulin-likegrowth factor-I receptor in prostate cancer cells. Cancer Res., 2005,65, 1849-1857.
13. Kim, S. H.; Richardson, M.; Chinnakannu, K.; Bai, V. U.; Menon, M.; Barrack, E. R.; Reddy, G. P. Androgen receptor interacts withtelomeric proteins in prostate cancer cells. J. Biol. Chem., 2010,(PMID: 20110352; Epub ahead of print).
14. Mayeur, G. L.; Kung, W. J.; Martinez, A.; Izumiya, C.; Chen, D. J.; Kung, H. J. Ku is a novel transcriptional recycling coactivator of theandrogen receptor in prostate cancer cells. J. Biol. Chem., 2005,280, 10827-10833.
15. Mani, R. S.; Tomlins, S. A.; Callahan, K.; Ghosh, A.; Nyati, M. K.; Varambally, S.; Palanisamy, N.; Chinnaiyan, A. M. Induced chromosomalproximity and gene fusions in prostate cancer. Science, 2009, 326, 1230.
16. Lin, C.; Yang, L.; Tanasa, B.; Hutt, K.; Ju, B. G.; Ohgi, K.; Zhang, J.; Rose, D. W.; Fu, X. D.; Glass, C. K.; Rosenfeld, M. G. Nuclear receptor-induced chromosomal proximity and DNA breaks underliespecific translocations in cancer. Cell, 2009, 139, 1069-1083.
17. De Klerk, D. P.; Coffey, D. S. Quantitative determination of prostaticepithelial and stromal hyperplasia by a new technique. Biomorphometrics. Invest. Urol., 1978, 16, 240-245.
18. Gao, J.; Arnold, J. T.; Isaacs, J. T. Conversion from a paracrine to anautocrine mechanism of androgen-stimulated growth during malignanttransformation of prostatic epithelial cells. Cancer Res., 2001, 61, 5038-5044.
19. Knudsen, K. E.; Arden, K. C.; Cavenee, W. K. Multiple G1 regulatoryelements control the androgen-dependent proliferation ofprostatic carcinoma cells. J. Biol. Chem., 1998, 273, 20213-20222.
20. Ye, D.; Mendelsohn, J.; Fan, Z. Androgen and epidermal growthfactor down-regulate cyclin-dependent kinase inhibitor p27Kip1and costimulate proliferation of MDA PCa 2a and MDA PCa 2bprostate cancer cells. Clin. Cancer Res., 1999, 5, 2171-2177.
21. Cifuentes, E.; Croxen, R.; Menon, M.; Barrack, E. R.; Reddy, G. P. Synchronized prostate cancer cells for studying androgen regulatedevents in cell cycle progression from G1 into S phase. J. Cell Physiol., 2003, 195, 337-345.
22. Reddy, G. P.; Cifuentes, E.; Menon, M.; Barrack, E. R. Steroidhormone and growth factor interaction in the regulation of cell cycleprogression. In Steroid Hormones and Cell Cycle Regulation., Burnstein, K. L., Ed. Kluwer Academic Publishers, The Netherlands, 2002; pp. 111-135.
23. Reddy, G. P. DNA Replication and S Phase. In The Molecular Basisof Cell Cycle and Growth Control. Stein, G. S.; Giordano, A.; Denhart, D. T., Eds. Wiley-Liss, Inc., USA, 1999; pp. 80-154.
24. Reddy, G. P.; Cifuentes, E.; Bai, U.; Menon, M.; Barrack, E. R. Onset of DNA synthesis and S phase. In Cell Cycle and Growth Control: Biological Regulation and Cancer. 2nd Ed.; Stein, G. S.; Pardee, A. B., Eds. John Wiley & Sons, Inc., USA 2004; pp. 149-200.
25. De Gregori, J.; Kowalik, T.; Nevins, J. R. Cellular targets for activationby the E2F1 transcription factor include DNA synthesis-andG1/S-regulatory genes. Mol. Cell Biol., 1995, 15, 4215-4224.
26. Hateboer, G.; Wobst, A.; Petersen, B. O.; Le Cam, L.; Vigo, E.; Sardet, C.; Helin, K. Cell cycle-regulated expression of mammalianCDC6 is dependent on E2F. Mol. Cell Biol., 1998, 18, 6679-6697.
27. Song, Y. J.; Stinski, M. F. Effect of the human cytomegalovirusIE86 protein on expression of E2F-responsive genes: a DNA microarrayanalysis. Proc. Natl. Acad. Sci. USA, 2002, 99, 2836-2841.
28. Bosco, G.; Du, W.; Orr-Weaver, T. L. DNA replication controlthrough interaction of E2F-RB and the origin recognition complex. Nat. Cell Biol., 2001, 3, 289-2895.
29. Coverley, D.; Laman, H.; Laskey, R. A. Distinct roles for cyclins Eand A during DNA replication complex assembly and activation. Nat. Cell Biol., 2002, 4, 523-528.
30. Furstenthal, L.; Kaiser, B. K.; Swanson, C.; Jackson, P. K. Cyclin Euses Cdc6 as a chromatin-associated receptor required for DNAreplication. J. Cell Biol., 2001, 152, 1267-1278.
31. Lu, S.; Tsai, S. Y.; Tsai, M. J. Regulation of androgen-dependentprostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res., 1997, 57, 4511-4516.
32. Taneja, S. S., Ha, S.; Garabedian, M. J. Androgen stimulated cellularproliferation in the human prostate cancer cell line LNCa P is associatedwith reduced retinoblastoma protein expression. J. Cell Biochem., 2002, 84, 188-199.
33. Fribourg, A. F.; Knudsen, K. E.; Strobeck, M. W.; Lindhorst, C. M.; Knudsen, E. S. Differential requirements for ras and the retinoblastomatumor suppressor protein in the androgen dependence ofprostatic adenocarcinoma cells. Cell Growth Differ., 2000, 11, 361-372.
34. Agus, D. B.; Cordon-Cardo, C.; Fox, W.; Drobnjak, M.; Koff, A.; Golde, D. W.; Scher, H. I. Prostate cancer cell cycle regulators: responseto androgen withdrawal and development of androgen independence. J. Natl. Cancer Inst., 1999, 91, 1869-1876.
35. Yamamoto, A.; Hashimoto, Y.; Kohri, K.; Ogata, E.; Kato, S.; Ikeda, K.; Nakanishi, M. Cyclin E as a coactivator of the androgenreceptor. J. Cell Biol., 2000, 150, 873-880.
36. Knudsen, K. E.; Cavenee, W. K.; Arden, K. C. D-type cyclins complexwith the androgen receptor and inhibit its transcriptional transactivationability. Cancer Res. 1999, 59, 2297-2301.
37. Reutens, A. T.; Fu, M.; Wang, C.; Albanese, C.; McPhaul, M. J.; Sun, Z.; Balk, S. P.; Janne, O. A.; Palvimo, J. J.; Pestell, R. G. Cyclin D1 binds the androgen receptor and regulates hormone-dependentsignaling in a p300/CBP-associated factor (P/CAF)-dependentmanner. Mol. Endocrinol., 2001, 15, 797-811.
38. Yeh, S.; Miyamoto, H.; Nishimura, K.; Kang, H.; Ludlow, J.; Hsiao, P.; Wang, C.; Su, C.; Chang, C. Retinoblastoma, a tumorsuppressor, is a coactivator for the androgen receptor in humanprostate cancer DU145 cells. Biochem. Biophys. Res. Commun., 1998, 248, 361-367.
39. Lu, J.; Danielsen, M. Differential regulation of androgen and glucocorticoidreceptors by retinoblastoma protein. J. Biol. Chem., 1998, 273, 31528-31533.
40. Muzi-Falconi, M.; Brown, G. W.; Kelly, T. J. Controlling initiationduring the cell cycle. DNA replication. Curr. Biol., 1996, 6, 229-233.
41. Bai, V. U.; Cifuentes, E.; Menon, M.; Barrack, E. R.; Reddy, G. P. Androgen receptor regulates Cdc6 in synchronized LNCa P cellsprogressing from G1 to S phase. J. Cell Physiol., 2005, 204, 381-387.
42. Jin, F.; Fondell, J. D. A novel androgen receptor-binding elementmodulates Cdc6 transcription in prostate cancer cells during cellcycleprogression. Nucleic Acids Res., 2009, 37, 4826-4838.
43. Mallik, I.; Davila, M.; Tapia, T.; Schanen, B.; Chakrabarti, R. Androgen regulates Cdc6 transcription through interactions betweenandrogen receptor and E2F transcription factor in prostatecancer cells. Biochim. Biophys. Acta, 2008, 1783, 1737-1744.
44. Robles, L. D.; Frost, A. R.; Davila, M.; Hutson, A. D.; Grizzle, W. E.; Chakrabarti, R. Down-regulation of Cdc6, a cell cycle regulatorygene, in prostate cancer. J. Biol. Chem., 2002, 277, 25431-2548.
45. D'Antonio, J. M.; Vander Griend, D. J.; Isaacs, J. T. DNA licensingas a novel androgen receptor mediated therapeutic target for prostatecancer. Endocr. Relat. Cancer, 2009, 16, 325-332.
46. Shi, Y. K.; Yu, Y. P.; Zhu, Z. H.; Han, Y. C.; Ren, B.; Nelson, J. B.; Luo, J. H. MCM7 interacts with androgen receptor. Am. J. Pathol., 2008, 173, 1758-1767.
47. Kozloff, L. M.; Lute, M.; Crosby, L. K. Bacteriophage T4 virionbaseplate thymidylate synthetase and dihydrofolate reductase. J. Virol., 1977, 23, 637-644.
48. Mosher, R. A.; Di Renzo, A. B.; Mathews, C. K. Bacteriophage T4virion dihydrofolate reductase: approaches to quantitation and assessmentof function. J. Virol., 1977, 23, 645-658.
49. Wistow, G. J.; Mulders, J. W.; de Jong, W. W. The enzyme lactatedehydrogenase as a structural protein in avian and crocodilianlenses. Nature, 1987, 326, 622-624.
50. Pardoll, D. M.; Vogelstein, B.; Coffey, D. S. A fixed site of DNAreplication in eucaryotic cells. Cell, 1980, 19, 527-536.
51. Cardoso, M. C.; Leonhardt, H.; Nadal-Ginard, B. Reversal of terminaldifferentiation and control of DNA replication: cyclin A andCdk2 specifically localize at subnuclear sites of DNA replication. Cell, 1993, 74, 979-992.
52. Adachi, Y.; Laemmli, U. K. Identification of nuclear pre-replicationcenters poised for DNA synthesis in Xenopus egg extracts: immunolocalizationstudy of replication protein A. J. Cell Biol., 1992,119, 1-15.
53. Kill, I. R.; Bridger, J. M.; Campbell, K. H.; Maldonado-Codina, G.; Hutchison, C. J. The timing of the formation and usage of replicaseclusters in S-phase nuclei of human diploid fibroblasts. J. Cell Sci., 1991, 100, 869-876.
54. Nakamura, H.; Morita, T.; Masaki, S.; Yoshida, S. Intracellularlocalization and metabolism of DNA polymerase alpha in humancells visualized with monoclonal antibody. Exp. Cell Res., 1984,151, 123-133.
55. Reddy, G. P.; Fager, R. S. Replitase: a complex integrating dNTPsynthesis and DNA replication. Crit., Rev. Eukaryot. Gene Expr., 1993, 3, 255-277.
56. Reddy, G. P. Catalytic function of thymidylate synthase is confinedto S phase due to its association with replitase. Biochem. Biophys. Res. Commun., 1982, 109, 908-915.
57. Reddy, G. P.; Pardee, A. B. Multienzyme complex for metabolicchanneling in mammalian DNA replication. Proc. Natl. Acad. Sci. USA, 1980, 77, 3312-3316.
58. Hammond, R. A.; Miller, M. R.; Gray, M. S.; Reddy, G. P. V. Associationof 3'----5' exodeoxyribonuclease activity with DNA replitasecomplex from S-phase Chinese hamster embryo fibroblastcells. Exp. Cell Res., 1989, 183, 284-293.
59. Noguchi, H.; Reddy, G. P.; Pardee, A. B. Rapid incorporation oflabel from ribonucleoside disphosphates into DNA by a cell-freehigh molecular weight fraction from animal cell nuclei. Cell, 1983,32, 443-451.
60. Jaumot, M.; Grana, X.; Giordano, A.; Reddy, G. P. V.; Agell, N.; Bachs, O. Cyclin/cdk2 complexes in the nucleus of He La cells. Biochem. Biophys. Res. Commun., 1994, 203, 1527-1534.
61. Murthy, S.; Reddy, G. P., Replitase: Complete machinery for DNAsynthesis. J. Cell Physiol., 2006, 209, 711-717.
62. Gilbert, D. M. Replication timing and transcriptional control: beyondcause and effect. Curr. Opin. Cell Biol., 2002, 14, 377-383.
63. Schwaiger, M.; Schubeler, D. A question of timing: emerging linksbetween transcription and replication. Curr. Opin. Genet. Dev., 2006, 16, 177-183.
64. Yunis, J. J.; Kuo, M. T.; Saunders, G. F. Localization of sequencesspecifying messenger RNA to light-staining G-bands of humanchromosomes. Chromosoma, 1977, 61, 335-344.
65. Holmquist, G.; Gray, M.; Porter, T.; Jordan, J. Characterization ofGiemsa dark-and light-band DNA. Cell, 1982, 31, 121-129.
66. De Pamphilis, M. L. Transcriptional elements as components ofeukaryotic origins of DNA replication. Cell, 1988, 52, 635-638.
67. Snyder, M.; Huang, X. Y.; Zhang, J. J. The minichromosome maintenanceproteins 2-7 (MCM2-7) are necessary for RNA polymeraseII (Pol II)-mediated transcription. J. Biol. Chem., 2009, 284, 13466-13472.
68. Litvinov, I. V.; Vander Griend, D. J.; Antony, L.; Dalrymple, S.; De Marzo, A. M.; Drake, C. G.; Isaacs, J. T. Androgen receptor as a licensingfactor for DNA replication in androgen-sensitive prostatecancer cells. Proc. Natl. Acad. Sci. USA, 2006, 103, 15085-15090.
69. Blow, J. J.; Hodgson, B. Replication licensing--defining the proliferativestate? Trends Cell Biol., 2002, 12, 72-78.
70. Schaufele, F.; Carbonell, X.; Guerbadot, M.; Borngraeber, S.; Chapman, M. S.; Ma, A. A.; Miner, J. N.; Diamond, M. I. The structuralbasis of androgen receptor activation: intramolecular and intermolecularamino-carboxy interactions. Proc. Natl. Acad. Sci. USA, 2005, 102, 9802-9807.
71. Narayanan, R.; Yepuru, M.; Szafran, A. T.; Szwarc, M.; Bohl, C. E.; Young, N. L.; Miller, D. D.; Mancini, M. A.; Dalton, J. T. Discoveryand mechanistic characterization of a novel selective nuclear androgenreceptor exporter for the treatment of prostate cancer. Cancer Res., 2010, 70, 842-851.
72. Pelley, R. P.; Chinnakannu, K.; Murthy, S.; Strickland, F. M.; Menon, M.; Dou, Q. P.; Barrack, E. R.; Reddy, G. P. Calmodulinandrogenreceptor (AR) interaction: calcium-dependent, calpainmediatedbreakdown of AR in LNCa P prostate cancer cells. Cancer Res., 2006, 66, 11754-11762.
73. Yang, H.; Murthy, S.; Sarkar, F. H.; Sheng, S.; Reddy, G. P.; Dou, Q. P. Calpain-mediated androgen receptor breakdown in apoptoticprostate cancer cells. J. Cell Physiol., 2008, 217, 569-576.
74. Shi, Q.; Shih, C. C.; Lee, K. H. Novel anti-prostate cancer curcuminanalogues that enhance androgen receptor degradation activity. Anticancer Agents Med. Chem., 2009, 9, 904-912.
75. Bechtel, P. E.; Hickey, R. J.; Schnaper, L.; Sekowski, J. W.; Long, B. J.; Freund, R.; Liu, N.; Rodriguez-Valenzuela, C.; Malkas, L. H. A unique form of proliferating cell nuclear antigen is present inmalignant breast cells. Cancer Res., 1998, 58, 3264-3269.